Background/Purpose: Bacteremia in dengue may occur with common exposure to pathogens in association with severe organ impairment or severe dengue, which may result in death. Cohort studies identifying risk factors for concurrent bacteremia among patients with dengue are rare. Methods: We conducted a retrospective caseecontrol study of adult patients with dengue who were admitted to the Department of Infectious Diseases at Tan Tock Seng Hospital, Singapore from 2004 to 2008. For each case of dengue with concurrent bacteremia (within the first 72 hours of admission), we selected four controls without bacteremia, who were matched on year of infection and dengue confirmation method. Conditional logistic regression was performed to identify risk factors for concurrent bacteremia. Results: Among 9,553 patients with dengue, 29 (0.3%) had bacteremia. Eighteen of these patients (62.1%) had concurrent bacteremia. The predominant bacteria were Staphylococcus aureus, one of which was a methicillin-resistant strain. Dengue shock syndrome occurred more frequently and hospital stay was longer among cases than among controls. Three cases did not survive, whereas none of the controls died. In multivariate analysis, being critically ill at Journal of Microbiology, Immunology and Infection (2015) xx, 1e7 hospital presentation was independently associated with 15 times the likelihood of a patient with dengue having concurrent bacteremia. Conclusion: Concurrent bacteremia in adult patients with dengue is uncommon but presents atypically and results in more deaths and longer hospital stay. Given the associated mortality, collection of blood cultures and empiric antibiotic therapy may be considered in patients who are critically ill.
Introduction
Dengue is an arbovirus-borne infection that is widespread in tropical and subtropical regions. 1 A recent model by Bhatt et al 2 estimated that 390 million infections occur annually, with 96 million of these infections being clinically apparent. Despite the high rate of infection worldwide, there is no effective vaccine against dengue. 3, 4 Clinical manifestations of dengue range from an asymptomatic infection to a mild, flu-like, self-limiting infection. 5 In adults, the infection can less commonly develop into the more severe and life-threatening forms, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Close monitoring and timely administration of fluid therapy have improved outcomes from DHF and DSS globally. 5, 6 More recently, the World Health Organization (WHO) proposed a new classification that better guides clinical management: dengue with warning signs, dengue without warning signs, and severe dengue. 5, 7 Only a few case series of concurrent bacteremia and dengue infection have been reported. Bacteremia in dengue may occur with common exposure to pathogens 8, 9 in association with severe organ impairment 10 or severe dengue, resulting in death. 11e13 In addition, nosocomial infection may result from prolonged hospitalization for severe dengue and its complications. 11 Hypotheses on the pathogenesis of concurrent bacteremia in patients with dengue include disintegration of endothelial cells by antibodies against dengue nonstructural protein 1 14, 15 and/or relative immunosuppression in patients with dengue. 11 A recent cohort study was carried out by Lee et al 16 to identify the clinical characteristics and risk factors of patients with DHF and concurrent bacteremia. However, large cohort studies identifying risk factors for patients with dengue and concurrent bacteremia are rare. In this large cohort study of adult patients with dengue who were admitted to the Department of Infectious Diseases at Tan Tock Seng Hospital (TTSH), Singapore from 2004 to 2008, we aimed to (1) determine the prevalence of concurrent bacteremia in adult patients with dengue; (2) describe the clinical characteristics of adult patients with dengue and concurrent bacteremia; and (3) identify clinical and laboratory risk factors for concurrent bacteremia at the time of hospital presentation. This information would be clinically useful for doctors performing appropriate microbiological investigations of bacteremia and starting early empiric antibiotic therapy.
Methods

Patients
We conducted a retrospective study of laboratorydiagnosed dengue in adult patients who were admitted to the Department of Infectious Diseases at TTSH from January 1, 2004 , to December 31, 2008 Patients were diagnosed as having probable dengue based on the 1997 and 2009 WHO guidelines. 5, 17 Dengue Real-time Reverse Transcription-Polymerase Chain Reaction, as described earlier, 18 or Panbio Rapid Dengue Duo Rapid Strip Test (Panbio Diagnostic, Queensland, Australia) 19, 20 was performed at the Department of Laboratory Medicine, TTSH, according to the manufacturer's instructions, to confirm the diagnosis. Diagnosis of bacteremia was confirmed by a positive bacterial culture in the patient's blood sample obtained after admission to the hospital. In this study, "concurrent bacteremia" was defined as a positive bacterial blood culture within 72 hours of a patient's admission. 16 Blood culture was taken in the event of clinical deterioration despite treatment based on a standardized dengue care path.
For each case of dengue with concurrent bacteremia, we selected four controls among patients with dengue without clinical suspicion of bacteremia or without blood cultures collected or reported as negative by the Department of Laboratory Medicine, TTSH, matched on year of infection (a surrogate for predominant circulating dengue serotype) and dengue confirmation method. The selection generated all controls without collection of blood cultures. In brief, 29 patients had bacteremia from 2004 to 2008, among which 18 had blood samples collected for bacterial culture within 72 hours of admission. Although the other 11 patients yielded positive results for bacterial growth, blood samples were collected >72 hours after admission. Therefore, it was not possible to determine whether bacteremia was concurrent with dengue infection or was acquired nosocomially. An analysis identifying risk factors was carried out with 72 controls and 18 cases.
Demographics (age, sex, and ethnicity), comorbidities (diabetes mellitus, hypertension, hyperlipidemia, and cardiac diseases), dengue diagnosis classification, symptoms and signs at presentation (Table 1) , parameters for laboratory investigation at presentation, types of intervention, dengue severity classification at hospital discharge, and clinical outcomes ( Table 2) were extracted for comparison between cases and controls. The laboratory parameters extracted included white blood cell count, absolute neutrophil count (ANC), lymphocyte count, platelet count, albumin, urea, aspartate aminotransferase, and alanine aminotransferase. DHF and DSS were defined according to the 1997 WHO guidelines, 17 whereas severe dengue was defined according to the 2009 WHO guidelines. 5 Charlson comorbidity index 21, 22 and Pitt bacteremia score (PBS) 23 were calculated for cases and controls.
Ethics approval
This study was approved by the Domain-Specific Review Board of the National Healthcare Group, Singapore. Informed consent from patients was waived.
Statistical analysis
Categorical variables were described in numbers and percentages. Medians and 5 th e95 th percentiles were used in the descriptive analysis of continuous variables. Univariate and multivariate logistic regressions were used to calculate odds ratios (ORs). 24 Confounding effect was removed by performing multivariate logistic regression, adjusted for potential cofounders identified in univariate analysis. All statistical analyses were performed using SPSS version 16 (SPSS Inc., Chicago, IL, USA) at a 5% level of significance, with adjusted ORs and corresponding 95% confidence intervals reported where applicable. 
Results
Among 9,553 patients with dengue, 29 (0.3%) had bacteremia. Fifteen patients were subjected to dengue Real-time Reverse Transcription-Polymerase Chain Reaction, whereas the remaining 14 patients met the criteria for probable dengue and had positive results for dengue serology test: 13 were immunoglobulin M-positive and one was immunoglobulin G-positive. We found four patients, nine patients, five patients, five patients, and six patients from 2004 to 2008, respectively. The predominant isolated bacteria in these patients were Staphylococcus aureus [14 of 29 (48.3%)], one of which was a methicillin-resistant strain. The other bacteria isolated included Salmonella Typhi (n Z 5), Escherichia coli (n Z 3), Klebsiella pneumoniae (n Z 2), Streptococcus species (alpha-hemolytic Streptococcus and Streptococcus milleri; n Z 2), Pseudomonas aeruginosa (n Z 1), Acinetobacter baumannii (n Z 1), and an unspecified anaerobe. Eighteen (62.1%) cases had their blood sampled for bacterial growth less than 72 hours after admission: Staphylococcus aureus (5 of 14), Salmonella Typhi (4 of 5), and all of the other bacteria except A. baumannii. Further analyses were performed for these 18 cases versus 72 controls.
Cases and controls were similar in age, sex, and comorbidities, including Charlson comorbidity index and duration of fever before presentation to the hospital. At presentation, significantly fewer cases met the 1997 WHO criteria for dengue fever [11 (61.1%) cases vs. 66 (91.7%) controls], but significantly more cases [5 (29. 4%)] than controls [1 (1.5%)] were critically ill (PBS 4). A significant proportion of cases had higher temperatures (median, 38.4 C vs. 37.6 C) but lower rates of hemorrhagic manifestations at presentation compared with controls [4 (22.2%) vs. 37 (51.4%); Table 1 ].
For common laboratory results, cases were significantly more likely than controls to have higher neutrophil counts and lower lymphocyte counts. In addition, cases were more likely than controls to have hemoconcentration (hematocrit change 20%) in association with lower platelet counts (<50,000 cells/L) and lower serum albumin levels. At the end of hospitalization, cases were significantly associated with DSS [3 (16.7%) cases vs. 1 (1.4%) control]. Cases and controls had similar rates of severe dengue according to the 2009 WHO classification. Not surprisingly, cases received more antibiotics, received more fluids (total volume and duration of fluid therapy), and stayed in the hospital longer than controls (median, 11 days vs. 4 days; p < 0.01). Three cases required intensive care admission and subsequently died, whereas none of the controls needed intensive care or died ( Table 2) . Two fatal cases experienced severe dengue shock (the Klebsiella case had elevated liver enzymes and the Pseudomonas case had pneumonia). The last fatal case experienced Salmonella septicemia with acute renal involvement. After adjustment for statistically and clinically significant univariate risk factors, a PBS of 4 (being critically ill) was found to be independently associated with concurrent bacteremia in patients with dengue (adjusted OR 14.73, 95% confidence interval 1.30e167.28; Table 3 ).
Discussion
Despite the existence of an integrated dengue prevention program, 25 dengue remains endemic to Singapore. From 2004 to 2008, the number of notified dengue cases was 41,234. Of the notified cases, 28 adults were confirmed to have died of dengue. Among these confirmed cases of dengue-related deaths, 14.3% had bacteremia. 13 In a mortality study of dengue at the National University Hospital in Singapore, bacteremia was associated with 44.4% of dengue-related deaths. 11 In another mortality study of dengue at TTSH, bacteremia was associated with 42.9% of deaths. 12 A study in Taiwan showed that 5.5% of patients with DHF had bacteremia. Among these patients with bacteremia, 28.6% did not survive. 16 A separate Taiwanese study identifying clinical and laboratory manifestations of fatal DHF showed that 37.5% of patients with DHF and concurrent bacteremia did not survive. 10 In our study, notably, only 16.7% of cases did not survive. The observed difference in mortality may be attributable to the fact that Taiwanese patients with bacteremia were older and had DHF.
In our study, 29 patients [representing a very small proportion (0.3%) of our cohort from 2004 to 2008] had bacteremia; among these patients, 18 had concurrent bacteremia. A recent study at the National University Hospital in Singapore reported that 10 of 25 isolates from patients with concurrent bacteremia were primary bacteremia. 26 In our study, all 18 cases had bacteria isolated solely from the bloodstream (without other obvious sources), indicating primary bacteremia. Fifteen of 18 cases were given antibiotics on the day of blood culture collection or later during hospitalization. Seven of 18 cases (39%) were Gram-positive bacteria, and 10 cases (56%) were Gram-negative bacteria. Among Gram-negative bacteria, five were Salmonella Typhi cases, representing common exposure. 27 The remaining Gram-negative bacteria were gastrointestinal tractecommensal, which may be associated with DSS; however, three of 18 patients had DSS, and none had gastrointestinal bleeding, which may predispose to bacterial translocation. A study of the 2010 dengue outbreak in São Paolo, Brazil, documented immune activation and microbial translocation in patients with severe dengue. 28 Several hypotheses on the pathogenesis of concurrent bacteremia in patients with dengue have been formulated. Antibodies against dengue virus nonstructural protein 1 have been observed to cross-react with endothelial cells, 14, 15 resulting in disintegration of endothelial cells via caspase-dependent apoptosis. 14, 29 The disintegration of endothelial cells may have facilitated the entry of bacteria into the bloodstream of patients with dengue. Another study revealed that the dengue virus could be isolated in human leukocytes 30 and that the titer of the virus correlated with the severity of the disease. 29, 31 Lahiri et al 11 postulated that leukocyte infection could cause relative immunosuppression in patients with dengue, contributing to susceptibility to concurrent bacteremia and high mortality rates in patients with bacteremia, as observed in previous studies. Consistent with the abovementioned hypotheses, a significant proportion of cases in our study had more events of DSS at hospital discharge.
Although most of the signs and symptoms at presentation were not significantly different between cases and controls, a significant proportion of our cases did not present with hemorrhagic manifestations. This was not reported in other dengue studies of concurrent bacteremia. Furthermore, patients with dengue and bacterial infection were more likely to be critically ill, as defined by the validated PBS. 23 PBS has been shown to be predictive of mortality in patients with intensive care uniteacquired sepsis. 32 Our results indicated that PBS can be used to detect the presence of concurrent bacteremia. Neutrophilia, lymphopenia, and hemoconcentration with significant thrombocytopenia may be suggestive as well. See et al 26 reported that patients with dengue and bacterial infection had higher ANC compared with patients with dengue without bacterial infection. However, See et al 26 reported that patients with dengue and bacterial infection had lower hematocrit and higher platelet count, contrary to our findings. These differences may be attributable to the inclusion of primary and secondary bacterial infections identified from blood or urine cultures in their cohort, whereas our study included cases with primary bacteremia only and our controls were matched on year of infection and dengue confirmation method. Cases required more medical resources. It is important to confirm dengue diagnosis in a timely manner and to triage patients who are likely to develop bacteremia for closer monitoring and early intervention.
Our study had several limitations. Its retrospective study design may have led to some inaccuracy, although our standardized dengue care path prospectively documented relevant symptoms and signs, and subjected all patients to full blood count, renal panel test, and liver panel test (which were repeated when the initial results yielded abnormal findings). Blood cultures were ordered as clinically indicated; most patients with confirmed dengue who did not undergo blood culture recovered without antibiotic therapy. The small sample size limited the number of variables assessed in the multivariate analysis. We studied adult patients with dengue who presented to a tertiary care infectious disease center in a developed country; thus, our findings and outcomes may not be generalizable to other populations (such as children) and settings (community hospitals and developing countries).
In conclusion, adult patients with dengue and concurrent bacteremia and adult patients with dengue without concurrent bacteremia have few differentiating predictive factors. Patients with dengue and concurrent bacteremia are more likely to have DSS, are more likely to be critically ill, have higher neutrophil count, lower lymphocyte count, and hemoconcentration with thrombocytopenia at hospital presentation. A high index of suspicion for bacteremia among critically ill adult patients with dengue is warranted. Given the associated mortality, collection of blood cultures and empiric antibiotic therapy may be considered in patients who are critically ill.
